跳至主要内容
临床试验/NCT04302532
NCT04302532已完成4 期

Combined Coenzyme Q10 and Clomiphene Citrate for Ovulation Induction in Clomiphene-citrate-resistant Polycystic Ovary Syndrome

Karachi Medical and Dental College1 个研究点 分布在 1 个国家目标入组 149 人开始时间: 2020年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
149
试验地点
1
主要终点
number of ovulating women

研究概览

简要总结

The study evaluates the effect of coenzyme q 10 on ovulation and subsequent pregnancy in women with polycystic ovarian syndrome. Half of the participants will receive coq10 and ovulation induction with clomiphene and other half would receive a placebo with clomiphene.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Diagnosis of polycystic ovarian syndrome PCOS based on the revised 2003 consensus on diagnostic criteria and long-term health risks related to PCOS (2003).
  • All women were previously treated with 100 mg of CC daily for 5 days per cycle, for two to three cycles with persistent anovulation or ovulate with very thin endometrium <5 mm at the time of hCG administration

排除标准

  • Non-consenting.
  • known autoimmune disorders
  • prior treatment of endometriosis or surgery to reproductive tract
  • prior history of pelvic inflammatory disease
  • those with tubal factors and uterine factors as assessed on history and confirmed by normal hysterosalpingogram.
  • Thyroid disorder as assessed by history examination and TSH level
  • Patients with raised FSH

研究组 & 干预措施

Clomiphene

Active Comparator

clomiphene citrate 150 mg once a day for 5 days

干预措施: clomiphene citrate (Drug)

clomiphene and coenzyme q10

Experimental

clomiphene citrate 150 mg once a day for 5 days and coenzyme q 10 120 mg each day

干预措施: Coenzyme Q10 (Drug)

clomiphene and coenzyme q10

Experimental

clomiphene citrate 150 mg once a day for 5 days and coenzyme q 10 120 mg each day

干预措施: clomiphene citrate (Drug)

结局指标

主要结局

number of ovulating women

时间窗: 1-2 months

transvaginal ultrasound as the disappearance of the leading follicle, presence of follicular fluid in the Douglas pouch and midluteal progesterone \>5 pg/ml.

number of pregnancies

时间窗: 1-2 months

ultrasound visualization of gestational sac with pulsating fetal pole

次要结局

未报告次要终点

研究者

发起方
Karachi Medical and Dental College
申办方类型
Other
责任方
Principal Investigator
主要研究者

samia husain

clinical investigator

Karachi Medical and Dental College

研究点 (1)

Loading locations...

相似试验